Royal DSM, the global Life Sciences and Materials Sciences Company, is pleased to announce a new collaboration between Somos®, a world leader in Additive Manufacturing materials, and EnvisionTEC, a world leader in 3D Printing equipment, that opens the door to new applications in the 3D Printing Industry.
EnvisionTEC unveiled its Xtreme® 3SP machine late last year at Euromold, which joined the Xede® 3SP in their large frame printing line. The 3SP® series’ proprietary Scan, Spin and Selectively Photocure technology provides for the fast 3D printing of large, high detail models with the precision and quality surface finish that EnvisionTEC is known for. EnvisionTEC is teaming up with Somos®, who has been developing game changing materials for over 25 years, to develop the next level of high performance materials designed for heat resistance, durability, high detail resolution and dimensional stability.
“Somos® consistently produces cutting edge materials for 3D Printing,” says John Hartner, Chief Operating Officer EnvisionTEC. “Working together will accelerate the possibility of producing large industrial parts with a high level of performance at much faster speeds.”
“We are very excited to be working with EnvisionTEC,” says Melissa Lutz, Business Director Somos®. “Their new 3SP® large frame machines produce parts 2 to 3 times faster than the existing industry leading equipment. We can’t wait to develop high performance materials that enable their equipment to expand into new industrial applications.”
DSM – Bright Science. Brighter Living.™
Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders simultaneously. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 25,000 employees. The company is listed on Euronext Amsterdam. More information can be found at www.dsm.com.
About Somos®
DSM believes that 3D printing is a major change agent for the world creating brighter lives for people today and generations to come. Somos®, a product brand of DSM, moves the Additive Manufacturing industry to a new level of performance. We are dedicated to helping our customers grow in the ever-changing world of 3D Printing and promote this growth through continuous material and application development, encouraging industry collaboration and maximizing customer asset value by providing continuous information and support. More information about Somos® can be found at www.dsm.com/somos.
About EnvisionTEC
EnvisionTEC is a leading global provider of professional grade 3D printing solutions for the rapid manufacture of customized products utilizing its proprietary consumables across a variety of markets. Since its first patent submission in 1999, EnvisionTEC has developed and released 3D print solutions consisting of 3D printers, print materials, replacement parts as well as training and other services. EnvisionTEC’s proprietary, multi-platform technology delivers high precision, speed, surface quality and functionality as well as the ability to use a wide range of materials at production speeds that it believes are superior to those offered by its competitors. EnvisionTEC works with a strong customer and partner base in diverse sectors such as jewelry, hearing aid, dental, consumer, auto manufacturing and design companies. For more information, please visit www. EnvisionTEC.com.
DSM Functional Materials
Kelly Hawkinson
Global Marketing & Communications Manager
tel. +1-847-608-2530
e-mail: kelly.hawkinson@dsm.com
Forward-looking statements
This press release may contain forward-looking statements with respect to DSM’s future (financial) performance and position. Such statements are based on current expectations, estimates and projections of DSM and information currently available to the company. DSM cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. DSM has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is leading.
related /
Medical Device Innovation and Advancement of Care Focus of FDA, VHA Collaboration
Spinal Devices, Electronics, & Collaboration: AM News Roundup for October 3-14
